WGS
GeneDx Holdings Corp.
$56.33
+8.75%
$1.5B
No data for this timeframe.
Vol
Market Cap$1.5B
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (92%)
Inst. Holders10 funds
Inst. Value$791.9M
Inst. Activity4 buys / 1 sells
Insider Activity14B / 11S
Insider Net $$52.6M
Reddit Sentiment58° Warm
SEC Reports5
Recent Activity
Jun 8, 2026
SEC
GeneDx Holdings Corp. (WGS) insiders show a mixed cluster: Director/10% owner Casdin Capital made a large open-market pu
CLUSTER — Impact 6/10
Jun 5, 2026
Insider
Casdin Capital, LLC bought 50,000 shares
Director @ $52.86 ($2.6M)
Jun 4, 2026
Insider
Casdin Capital, LLC bought 150,000 shares
Director @ $56.44 ($8.5M)
Jun 1, 2026
Insider
Feeley Kevin sold 717 shares
CHIEF FINANCIAL OFFICER @ $0.00 ($0.00)
May 20, 2026
SEC
Two large-position insiders at GeneDx (WGS) — Casdin Capital (a director/10% owner) and director Keith Meister — purchas
CLUSTER — Impact 6/10
Mar 30, 2026
SEC
Analysis based on filing metadata only — document content was unavailable. Cross-filing context reveals an insider tradi
CLUSTER — Impact 6/10
Inst.
FMR LLC — ADD
832,738 shares ($108.3M)
Inst.
NORGES BANK — NEW
68,000 shares ($8.8M)
Price Targets
$77.00
+36.7% upside
Strong Buy
Current $56.33
Low $50.00
Median $75.00
High $100.00
9 analysts
$50.00
$100.00
Analyst Ratings
4Strong Buy
8Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 5, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
| May 5, 2026 | Wells Fargo | MAINTAIN | Overweight → Overweight |
| May 5, 2026 | Guggenheim | MAINTAIN | Buy → Buy |
| May 5, 2026 | BTIG | MAINTAIN | Buy → Buy |
| Apr 20, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.19 ▼ -262.0% | $-0.30 — $-0.16 | -138% YoY | 8 |
| Next Q | $0.12 ▼ -67.5% | $-0.15 — $0.21 | -77% YoY | 8 |
| Current FY | $0.11 ▼ -87.9% | $-0.69 — $1.38 | -92% YoY | 8 |
| Next FY | $1.23 ▼ -40.1% | $0.41 — $2.37 | 1019% YoY | 8 |
Latest Reports
BULLISH
CLUSTER
6/10
GeneDx Holdings Corp. (WGS) insiders show a mixed cluster: Director/10% owner Casdin Capital made a large open-market pu
Jun 8, 2026
BULLISH
CLUSTER
6/10
Two large-position insiders at GeneDx (WGS) — Casdin Capital (a director/10% owner) and director Keith Meister — purchas
May 20, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| Corvex Management LP | $397.8M | EXIT |
| VANGUARD GROUP INC | $154.7M | — |
| FMR LLC | $108.3M | ADD |
| MORGAN STANLEY | $65.8M | DOUBLED |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $23.0M | NEW |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 5, 2026 | Casdin Capital, | BUY | $2.6M |
| Jun 4, 2026 | Casdin Capital, | BUY | $8.5M |
| Jun 1, 2026 | Feeley Kevin | M | $0.00 |
| Jun 1, 2026 | Feeley Kevin | M | $0.00 |
| Jun 1, 2026 | Feeley Kevin | SELL | $19.1K |
Reddit Sentiment
58°
Warm
Bearish
Neutral
Bullish
10 institutional holders with $791.9M total value (6,088,908 shares) as of 2025-Q4. Top holders: Corvex, VANGUARD, FMR. Net buying activity: 4 institutions added/increased vs 1 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | Corvex Management LP | 3,058,629 | $397.8M | 50.2% | EXIT -100.0% |
| 2 | VANGUARD GROUP INC | 1,189,069 | $154.7M | 19.5% | — |
| 3 | FMR LLC | 832,738 | $108.3M | 13.7% | ADD +65.5% |
| 4 | MORGAN STANLEY | 506,091 | $65.8M | 8.3% | DOUBLED +129.2% |
| 5 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 177,030 | $23.0M | 2.9% | NEW |
| 6 | BANK OF AMERICA CORP /DE/ | 132,150 | $17.2M | 2.2% | DOUBLED +156.8% |
| 7 | NORGES BANK | 68,000 | $8.8M | 1.1% | NEW |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 57,316 | $7.5M | 0.9% | NEW |
| 9 | WELLS FARGO & COMPANY/MN | 42,911 | $5.6M | 0.7% | ADD +48.3% |
| 10 | TWO SIGMA INVESTMENTS, LP | 24,974 | $3.2M | 0.4% | NEAR_EXIT -80.9% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| FMR LLC | ADD | 503,309 | 832,738 | +65.5% | $108.3M | 2025-Q4 |
| NORGES BANK | NEW | — | 68,000 | — | $8.8M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 57,316 | — | $7.5M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 28,926 | 42,911 | +48.3% | $5.6M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | NEAR_EXIT | 130,433 | 24,974 | -80.9% | $3.2M | 2025-Q4 |
| FMR LLC | DOUBLED | 163,324 | 503,309 | +208.2% | $54.2M | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 1,010,720 | 149,789 | -85.2% | $16.1M | 2025-Q3 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 14,274 | 28,926 | +102.6% | $3.1M | 2025-Q3 |
| NORGES BANK | EXIT | 68,000 | 0 | -100.0% | $0.00 | 2025-Q3 |
| UBS Group AG | DOUBLED | 52,141 | 1,010,720 | +1838.4% | $93.3M | 2025-Q2 |
| MORGAN STANLEY | DOUBLED | 212,466 | 487,070 | +129.2% | $45.0M | 2025-Q2 |
| FMR LLC | NEAR_EXIT | 2,793,953 | 163,324 | -94.2% | $15.1M | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 60,837 | 156,226 | +156.8% | $14.4M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 28,358 | 122,749 | +332.9% | $11.3M | 2025-Q2 |
| NORGES BANK | NEW | — | 68,000 | — | $6.3M | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 70,216 | 0 | -100.0% | $0.00 | 2025-Q2 |
| FMR LLC | DOUBLED | 402,494 | 2,793,953 | +594.2% | $247.4M | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 205,116 | 70,216 | -65.8% | $6.2M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | NEAR_EXIT | 152,073 | 28,358 | -81.4% | $2.5M | 2025-Q1 |
| WELLS FARGO & COMPANY/MN | ADD | 8,382 | 13,668 | +63.1% | $1.2M | 2025-Q1 |
| NORGES BANK | EXIT | 68,000 | 0 | -100.0% | $0.00 | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 93,573 | 205,116 | +119.2% | $15.8M | 2024-Q4 |
| CITADEL ADVISORS LLC | ADD | 114,205 | 182,190 | +59.5% | $14.0M | 2024-Q4 |
| NORGES BANK | NEW | — | 68,000 | — | $5.2M | 2024-Q4 |
| UBS Group AG | DOUBLED | 13,416 | 46,905 | +249.6% | $3.6M | 2024-Q4 |
5 unique insiders with 25 transactions. Net insider value: $52.6M ($55.5M bought, $2.9M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Casdin Capital, LLC | Director | BUY | 50,000 | $52.86 | $2.6M |
| Jun 4, 2026 | Casdin Capital, LLC | Director | BUY | 150,000 | $56.44 | $8.5M |
| Jun 1, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | 717 | $0.00 | $0.00 |
| Jun 1, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | 717 | $0.00 | $0.00 |
| Jun 1, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | SELL | 369 | $51.74 | $19.1K |
| May 20, 2026 | Casdin Capital, LLC | Director | BUY | 140,000 | $43.81 | $6.1M |
| May 19, 2026 | Casdin Capital, LLC | Director | BUY | 185,000 | $42.60 | $7.9M |
| May 18, 2026 | Casdin Capital, LLC | Director | BUY | 175,000 | $42.55 | $7.4M |
| May 15, 2026 | Meister Keith A. | Director | BUY | 27,408 | $38.28 | $1.0M |
| May 14, 2026 | Meister Keith A. | Director | BUY | 88,107 | $39.08 | $3.4M |
| May 13, 2026 | Meister Keith A. | Director | BUY | 94,074 | $38.82 | $3.7M |
| May 11, 2026 | Casdin Capital, LLC | Director | BUY | 50,000 | $0.00 | $0.00 |
| May 11, 2026 | Meister Keith A. | Director | BUY | 246,734 | $38.91 | $9.6M |
| May 8, 2026 | Casdin Capital, LLC | Director | BUY | 300,000 | $0.00 | $0.00 |
| May 8, 2026 | Meister Keith A. | Director | BUY | 15,745 | $38.00 | $598.3K |
| May 7, 2026 | Casdin Capital, LLC | Director | BUY | 500,000 | $0.00 | $0.00 |
| May 7, 2026 | Meister Keith A. | Director | BUY | 128,181 | $35.46 | $4.5M |
| Apr 29, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | SELL | 392 | $65.19 | $25.6K |
| Apr 29, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | 754 | $0.00 | $0.00 |
| Apr 29, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | 754 | $0.00 | $0.00 |
| Apr 29, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | 3,874 | $0.00 | $0.00 |
| Apr 29, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | SELL | 2,154 | $65.20 | $140.4K |
| Apr 29, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | 3,874 | $0.00 | $0.00 |
| Mar 26, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | 80,000 | $0.00 | $0.00 |
| Mar 26, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | SELL | 13,229 | $61.29 | $810.8K |
| Mar 26, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | 80,000 | $0.00 | $0.00 |
| Mar 26, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | SELL | 2,485 | $61.29 | $152.3K |
| Mar 26, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | 16,250 | $0.00 | $0.00 |
| Mar 26, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | 16,250 | $0.00 | $0.00 |
| Mar 16, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | 18,750 | $0.00 | $0.00 |
| Mar 16, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | 7,197 | $0.00 | $0.00 |
| Mar 16, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | SELL | 2,384 | $76.35 | $182.0K |
| Mar 16, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | 7,197 | $0.00 | $0.00 |
| Mar 16, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | SELL | 7,178 | $76.35 | $548.0K |
| Mar 16, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | 18,750 | $0.00 | $0.00 |
| Mar 15, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | 3,815 | $0.00 | $0.00 |
| Mar 15, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | 3,815 | $0.00 | $0.00 |
| Mar 15, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | 11,921 | $0.00 | $0.00 |
| Mar 15, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | 11,921 | $0.00 | $0.00 |
| Mar 9, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | 6,546 | $0.00 | $0.00 |
| Mar 9, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | SELL | 3,678 | $86.75 | $319.1K |
| Mar 9, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | 6,546 | $0.00 | $0.00 |
| Mar 9, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | 2,462 | $0.00 | $0.00 |
| Mar 9, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | M | 2,462 | $0.00 | $0.00 |
| Mar 9, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | SELL | 1,280 | $86.75 | $111.0K |
| Mar 6, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | A | 1,986 | $88.11 | $175.0K |
| Mar 6, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | A | 3,404 | $88.11 | $299.9K |
| Mar 4, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | SELL | 1,424 | $77.63 | $110.5K |
| Mar 4, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | SELL | 5,861 | $77.63 | $455.0K |
| Mar 3, 2026 | Dechairo Bryan | Chief Operating Officer | A | 10,430 | $0.00 | $0.00 |
5 SEC filing reports analyzed. Sentiment: 2 bullish, 2 bearish, 0 mixed, 1 neutral. Avg impact: 5.6/10.
BULLISH
CLUSTER
6/10
GeneDx Holdings Corp. (WGS) insiders show a mixed cluster: Director/10% owner Casdin Capital made a
Jun 8, 2026
BULLISH
CLUSTER
6/10
Two large-position insiders at GeneDx (WGS) — Casdin Capital (a director/10% owner) and director Kei
May 20, 2026
BEARISH
CLUSTER
6/10
Analysis based on filing metadata only — document content was unavailable. Cross-filing context reve
Mar 30, 2026
BEARISH
CLUSTER
6/10
GeneDx CEO Katherine Stueland sold $455K in open-market shares while receiving a large non-cash stoc
Mar 9, 2026
NEUTRAL
CLUSTER
4/10
GeneDx CEO and CFO conducted open-market share sales totaling $587,754 over four days, while also re
Mar 5, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (92% buy). Based on 13 analysts: 4 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$77.00 mean target
+36.7% upside
Strong Buy (1.11)
$50.00 Low
$100.00 High
| Metric | Value |
|---|---|
| Current Price | $56.33 |
| Target Low | $50.00 |
| Target Mean | $77.00 |
| Target Median | $75.00 |
| Target High | $100.00 |
| # Analysts | 9 |
| Recommendation | Strong Buy (1.11) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.19 | $-0.30 | $-0.16 | -137.5% | -262.0% | 0↑ 6↓ | $0.1B | 8.1% | 8 |
| Next Q 2026-09-30 |
$0.12 | $-0.15 | $0.21 | -76.5% | -67.5% | 0↑ 5↓ | $0.1B | 8.0% | 8 |
| Current FY 2026-12-31 |
$0.11 | $-0.69 | $1.38 | -92.1% | -87.9% | 0↑ 2↓ | $0.5B | 11.9% | 8 |
| Next FY 2027-12-31 |
$1.23 | $0.41 | $2.37 | 1019.3% | -40.1% | 1↑ 5↓ | $0.6B | 24.4% | 8 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.188 | |
| 7d ago | $0.116 | -0.303 |
| 30d ago | $0.116 | -0.303 |
| 60d ago | $0.116 | -0.303 |
| 90d ago | $0.095 | -0.282 |
5 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 5, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| May 5, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| May 5, 2026 | Guggenheim | MAINTAIN | Buy | Buy |
| May 5, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Apr 20, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Mar 30, 2026 | Guggenheim | MAINTAIN | Buy | Buy |
| Feb 24, 2026 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Feb 24, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Feb 9, 2026 | Wells Fargo | UPGRADE | Equal-Weight | Overweight |
| Dec 22, 2025 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Dec 15, 2025 | Wells Fargo | MAINTAIN | Equal-Weight | Equal-Weight |
| Dec 12, 2025 | BTIG | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 8 | 1 | 0 | 0 | 92% | |
| May 1, 2026 | 4 | 8 | 1 | 0 | 0 | 92% | |
| Apr 1, 2026 | 4 | 8 | 1 | 0 | 0 | 92% | |
| Mar 1, 2026 | 4 | 8 | 1 | 0 | 0 | 92% | |
| Feb 1, 2026 | 4 | 7 | 2 | 0 | 0 | 85% | |
| Jan 1, 2026 | 4 | 7 | 2 | 0 | 0 | 85% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
58°
Warm
Bearish
Neutral
Bullish
2 mentions
1 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Jan 2, 2025 | 1 | 50° Neutral | 0 | 0 | 1 |
| Dec 6, 2024 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
06 MAY 2026 , WHAT ARE THE BIGGEST LOSERS AND WHY ?
▲ 1
💬 1
⚡ 0.2
WGS GeneDx stock
▲ 1
💬 1
⚡ 0.0
WGS GeneDx stock bullish, lets go!
▲ 1
💬 1
⚡ 0.0
May 19, 2026
short_volume
Short Volume: WGS — 62.8% short (0.3M / 0.5M)
Short: 320,518 | Exempt: 99 | TRF Vol: 510,219 | Short Ratio: 62.8% | Off-exchange volume (dark pool + OTC)
May 18, 2026
short_volume
Short Volume: WGS — 61.2% short (0.4M / 0.6M)
Short: 391,299 | Exempt: 140 | TRF Vol: 639,215 | Short Ratio: 61.2% | Off-exchange volume (dark pool + OTC)
May 15, 2026
short_volume
Short Volume: WGS — 55.3% short (0.3M / 0.6M)
Short: 340,427 | Exempt: 0 | TRF Vol: 615,427 | Short Ratio: 55.3% | Off-exchange volume (dark pool + OTC)
May 14, 2026
short_volume
Short Volume: WGS — 64.3% short (0.4M / 0.6M)
Short: 387,425 | Exempt: 0 | TRF Vol: 602,973 | Short Ratio: 64.3% | Off-exchange volume (dark pool + OTC)
May 6, 2026
short_interest
FTD: WGS — 21,188 shares ($0.7M) failed to deliver
Settlement: 20260506, Price: $34.51, FTD Value: $731,197.88, GENEDX HLDGS CORP CL A NEW
May 5, 2026
short_volume
Short Volume: WGS — 57.8% short (3.2M / 5.5M)
Short: 3,164,006 | Exempt: 148,188 | TRF Vol: 5,475,918 | Short Ratio: 57.8% | Off-exchange volume (dark pool + OTC)
May 5, 2026
short_interest
FTD: WGS — 22,155 shares ($1.5M) failed to deliver
Settlement: 20260505, Price: $67.93, FTD Value: $1,504,989.15, GENEDX HLDGS CORP CL A NEW
May 4, 2026
earnings_calendar
WGS Q1 2026 Earnings Scheduled — 2026-05-04
Mar 30, 2026
short_volume
Short Volume: WGS — 59.0% short (0.3M / 0.6M)
Short: 342,914 | Exempt: 28,555 | TRF Vol: 581,076 | Short Ratio: 59.0% | Off-exchange volume (dark pool + OTC)
Feb 23, 2026
earnings_calendar
WGS Q4 2025 Earnings Before Market Open — 2026-02-23